Other Species / Isoforms
  LLGL1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K17-ub
GADPQREkLkQELFA
0 3
LLGL1 (human) GADPQREkLkQELFA K17-ub
LLGL1 (mouse) GADPQREKLKQELFA K17
LLGL1 (rat) GADPQREKLKQELFT K17
K19-ub
DPQREkLkQELFAFN
0 5
LLGL1 (human) DPQREkLkQELFAFN K19-ub
LLGL1 (mouse) DPQREKLKQELFAFH K19
LLGL1 (rat) DPQREKLKQELFTFH K19
K27-ub
QELFAFNkTVEHGFP
0 3
LLGL1 (human) QELFAFNkTVEHGFP K27-ub
LLGL1 (mouse) QELFAFHKTVEHGFP K27
LLGL1 (rat) QELFTFHKTVEHGFP K27
K59-ub
GTRSGAVkIYGAPGV
0 2
LLGL1 (human) GTRSGAVkIYGAPGV K59-ub
LLGL1 (mouse) GTRSGAVKIYGAPGV K59
LLGL1 (rat) GTRSGAVKIYGAPGV K59
K293-ub
FPCKAINkILWRNCE
0 2
LLGL1 (human) FPCKAINkILWRNCE K293-ub
LLGL1 (mouse) FPCKAINKILWRSCE K292
LLGL1 (rat) FPCKAINKILWRSCE K292
S488-p
TDCEHADsLAQAAED
0 2
LLGL1 (human) TDCEHADsLAQAAED S488-p
LLGL1 (mouse) TDCEHADSLAQAVED S487
LLGL1 (rat) TDCEHADSLAQAVED S487
K502-ub
DDWPPFRkVGCFDPy
0 3
LLGL1 (human) DDWPPFRkVGCFDPy K502-ub
LLGL1 (mouse) DDWPPFRKVGCFDPy K501
LLGL1 (rat) DDWPPFRKVGCFDPy K501
Y509-p
kVGCFDPysDDPRLG
Upstream
0 95
Treatment
  • gefitinib
LLGL1 (human) kVGCFDPysDDPRLG Y509-p
LLGL1 (mouse) KVGCFDPySDDPRLG Y508-p
LLGL1 (rat) KVGCFDPySDDPRLG Y508-p
S510-p
VGCFDPysDDPRLGV
0 2
LLGL1 (human) VGCFDPysDDPRLGV S510-p
LLGL1 (mouse) VGCFDPySDDPRLGI S509
LLGL1 (rat) VGCFDPySDDPRLGI S509
K519-ub
DPRLGVQkVALCKYt
0 3
LLGL1 (human) DPRLGVQkVALCKYt K519-ub
LLGL1 (mouse) DPRLGIQKVALCKYT K518
LLGL1 (rat) DPRLGIQKVALCKYT K518
T526-p
kVALCKYtAQMVVAG
0 1
LLGL1 (human) kVALCKYtAQMVVAG T526-p
LLGL1 (mouse) KVALCKYTAQMVVAG T525
LLGL1 (rat) KVALCKYTAQMVVAG T525
S553-p
VPVEQAVsVAIIDLL
0 1
LLGL1 (human) VPVEQAVsVAIIDLL S553-p
LLGL1 (mouse) VPAEHAVSVANVDLL S552
LLGL1 (rat) VPGEHTVSVASVDLL S552
T567-p
LQDREGFtWkGHERL
0 1
LLGL1 (human) LQDREGFtWkGHERL T567-p
LLGL1 (mouse) LQDREGFTWKGHERL T566
LLGL1 (rat) LQDREGFTWKGHERL T566
K569-ub
DREGFtWkGHERLSP
0 2
LLGL1 (human) DREGFtWkGHERLSP K569-ub
LLGL1 (mouse) DREGFTWKGHERLNP K568
LLGL1 (rat) DREGFTWKGHERLSP K568
S651
LAMEGPLSRVKsLKK
1 0
LLGL1 (human) LAMEGPLSRVKsLKK S651
LLGL1 (mouse) LAMEGPLsRVKsLKK S650-p
LLGL1 (rat) LAMEGPLSRVKSLKK S650
S655-p
GPLSRVKsLKKsLRQ
Upstream
Downstream
2 5
Effects on Modified Protein
  • intracellular localization
Putative in vivo kinases:
  • PKCT (human)
LLGL1 (human) GPLSRVKsLKKsLRQ S655-p
LLGL1 (mouse) GPLsRVKsLKKsLRQ S654-p
LLGL1 (rat) GPLSRVKSLKKsLRQ S654
S659-p
RVKsLKKsLRQsFRR
Upstream
Downstream
2 17
Effects on Modified Protein
  • intracellular localization
Putative in vivo kinases:
  • PKCT (human)
Treatment
  • angiotensin_2
LLGL1 (human) RVKsLKKsLRQsFRR S659-p
LLGL1 (mouse) RVKsLKKsLRQsFRR S658-p
LLGL1 (rat) RVKSLKKsLRQsFRR S658-p
S663-p
LKKsLRQsFRRIRKs
Upstream
Downstream
3 23
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • PKCI (mouse)
Putative in vivo kinases:
  • PKCI (mouse)
  • PKCT (human)
Treatment
  • angiotensin_2
LLGL1 (human) LKKsLRQsFRRIRKs S663-p
LLGL1 (mouse) LKKsLRQsFRRIRKS S662-p
LLGL1 (rat) LKKsLRQsFRRIRKS S662-p
S670-p
sFRRIRKsRVsGKKR
Upstream
Downstream
1 1
Effects on Modified Protein
  • intracellular localization
Putative in vivo kinases:
  • PKCT (human)
LLGL1 (human) sFRRIRKsRVsGKKR S670-p
LLGL1 (mouse) sFRRIRKSRVsGKKR S669
LLGL1 (rat) sFRRIRKSRVSGKKR S669
S673-p
RIRKsRVsGKKRAAN
Upstream
Downstream
2 0
Effects on Modified Protein
  • intracellular localization
Putative in vivo kinases:
  • PKCT (human)
LLGL1 (human) RIRKsRVsGKKRAAN S673-p
LLGL1 (mouse) RIRKSRVsGKKRTPA S672-p
LLGL1 (rat) RIRKSRVSGKKRATT S672
K684-ub
RAANASSkLQEANAQ
0 2
LLGL1 (human) RAANASSkLQEANAQ K684-ub
LLGL1 (mouse) RTPAASSKLQEANAQ K683
LLGL1 (rat) RATTASSKLQEANAQ K683
T704-p
CPHDVEMtPVQRRIE
0 5
LLGL1 (human) CPHDVEMtPVQRRIE T704-p
LLGL1 (mouse) CPHDLEMTPVQRRIE T703
LLGL1 (rat) CPHDVEMTPVQRRIE T703
K780-ub
AVEAVLGkEVQLMHR
0 2
LLGL1 (human) AVEAVLGkEVQLMHR K780-ub
LLGL1 (mouse) AVEAVLGKEVQLMHR K779
LLGL1 (rat) AVEAVLGKEVQLMHR K779
K840-ub
FKVFTLPkVSAKTKF
0 2
LLGL1 (human) FKVFTLPkVSAKTKF K840-ub
LLGL1 (mouse) FKVFTLPkVSAKTKF K839-ub
LLGL1 (rat) FKVFTLPKVSAKTKF K839
K848-ub
VSAKTKFkLTAHEGC
0 2
LLGL1 (human) VSAKTKFkLTAHEGC K848-ub
LLGL1 (mouse) VSAKTKFKLTAHEGC K847
LLGL1 (rat) VSAKTKFKLTAHEGC K847
K906-ub
VHYSCIRkEDISGIA
0 3
LLGL1 (human) VHYSCIRkEDISGIA K906-ub
LLGL1 (mouse) VHYSCIRkEDISGIA K905-ub
LLGL1 (rat) VHYSCIRKEDISGIA K905
S961-p
PRDATQAsYRIREsP
0 1
LLGL1 (human) PRDATQAsYRIREsP S961-p
LLGL1 (mouse) PQNATQPRLQEsPKL R960
LLGL1 (rat) PQNATQPRLQEsPKL R960
S967-p
AsYRIREsPKLSQAN
0 19
LLGL1 (human) AsYRIREsPKLSQAN S967-p
LLGL1 (mouse) TQPRLQEsPKLsQAN S964-p
LLGL1 (rat) TQPRLQEsPKLSQAN S964-p
S971
IREsPKLSQANGTPS
0 5
LLGL1 (human) IREsPKLSQANGTPS S971
LLGL1 (mouse) LQEsPKLsQANGTRD S968-p
LLGL1 (rat) LQEsPKLSQANGTRD S968
S985
SILLAPQSLDGSPDP
0 11
LLGL1 (human) SILLAPQSLDGSPDP S985
LLGL1 (mouse) DIILAPEsCEGsPss S982-p
LLGL1 (rat) DIILAPESCEGsPSS S982
S989
APQSLDGSPDPAHSM
0 13
LLGL1 (human) APQSLDGSPDPAHSM S989
LLGL1 (mouse) APEsCEGsPssAHsK S986-p
LLGL1 (rat) APESCEGsPSSAHSK S986-p
D991
QSLDGSPDPAHSMGP
0 1
LLGL1 (human) QSLDGSPDPAHSMGP D991
LLGL1 (mouse) EsCEGsPssAHsKRA S988-p
LLGL1 (rat) ESCEGsPSSAHSKRA S988
P992
SLDGSPDPAHSMGPD
0 4
LLGL1 (human) SLDGSPDPAHSMGPD P992
LLGL1 (mouse) sCEGsPssAHsKRAD S989-p
LLGL1 (rat) SCEGsPSSAHSKRAD S989
S995
GSPDPAHSMGPDTPE
0 4
LLGL1 (human) GSPDPAHSMGPDTPE S995
LLGL1 (mouse) GsPssAHsKRADTME S992-p
LLGL1 (rat) GsPSSAHSKRADTME S992
S1040-p
DVKDFLGsSEEsEkN
0 1
LLGL1 (human) DVKDFLGsSEEsEkN S1040-p
LLGL1 (mouse) gap -
LLGL1 (rat) gap -
S1044-p
FLGsSEEsEkNLRNL
0 1
LLGL1 (human) FLGsSEEsEkNLRNL S1044-p
LLGL1 (mouse) gap -
LLGL1 (rat) gap -
K1046-ub
GsSEEsEkNLRNLAE
0 2
LLGL1 (human) GsSEEsEkNLRNLAE K1046-ub
LLGL1 (mouse) gap -
LLGL1 (rat) gap -